Dishman Carbogen Amcis Ltd
DCALDishman Carbogen Amcis Ltd
DCAL
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -53.18 | 0.44 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.48 | 5.11 | 0.70% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Dishman Carbogen Amicis Limited is an India-based contract research and manufacturing services (CRAMS) company. The Company is engaged in the process of research and development to late-stage clinical and commercial manufacturing
Investor Presentation
View olderPeers
Compare with peersDivi's Laboratories Ltd
Syngene International Ltd
Aarti Pharmalabs Ltd
Vimta Labs Ltd
Brooks Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.45 | 7.13 | 1,739.82 | 1,740.48 | 2,112.42 | 2,088.06 | 1,950.48 | 2,184.11 | 2,440.69 | 2,596.57 | ||||||||||
Raw Materials | 0.00 | 0.00 | 329.58 | 402.19 | 378.01 | 476.38 | 434.77 | 460.50 | 624.99 | 2,271.50 | ||||||||||
| Power & Fuel Cost | 0.00 | 49.47 | 48.33 | 56.14 | 60.26 | 41.87 | 62.73 | 87.83 | ||||||||||||
| Employee Cost | 0.00 | 596.02 | 625.40 | 714.64 | 762.27 | 872.91 | 981.49 | 1,035.27 | ||||||||||||
| Selling & Administrative Expenses | 5.08 | 147.69 | 136.29 | 190.73 | 124.58 | 113.81 | 147.71 | 197.65 | ||||||||||||
| Operating & Other expenses | 0.05 | 138.47 | 37.23 | 167.18 | 122.55 | 196.60 | 171.53 | 183.13 | ||||||||||||
EBITDA | 0.45 | 2.00 | 478.59 | 491.04 | 605.72 | 542.02 | 290.52 | 360.15 | 311.82 | 325.07 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 213.50 | 211.42 | 240.38 | 282.87 | 307.94 | 307.59 | 280.72 | 271.56 | ||||||||||
| PBIT | 0.45 | 2.00 | 265.09 | 279.62 | 365.34 | 259.15 | -17.42 | 52.56 | 31.10 | 53.51 | ||||||||||
| Interest & Other Items | 0.94 | 0.99 | 49.01 | 48.83 | 56.55 | 61.95 | 47.61 | 56.81 | 85.69 | 102.28 | ||||||||||
| PBT | -0.49 | 1.01 | 216.08 | 230.79 | 308.79 | 197.20 | -65.03 | -4.25 | -54.59 | -48.77 | ||||||||||
| Taxes & Other Items | 0.00 | 0.12 | 70.65 | 76.22 | 98.46 | 38.69 | 100.10 | -22.26 | -24.79 | -1.11 | ||||||||||
| Net Income | -0.49 | 0.89 | 145.43 | 154.57 | 210.33 | 158.51 | -165.13 | 18.01 | -29.80 | -47.66 | ||||||||||
| EPS | -19.60 | 35.60 | 11,634.40 | 19.15 | 13.03 | 9.96 | -10.53 | 1.15 | -1.90 | -3.04 | ||||||||||
| DPS | 0.00 | 0.00 | 1.20 | 0.00 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Peers & Comparison
Health CareLabs & Life Sciences Services
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Dishman Carbogen Amcis Ltd | -85.05 | 0.44 | — |
| Divi's Laboratories Ltd | 54.37 | 7.76 | 0.80% |
| Syngene International Ltd | 62.75 | 8.05 | 0.17% |
| Aarti Pharmalabs Ltd | 22.14 | 2.75 | — |
Price Comparison
Compare DCAL with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 4 Mutual Funds holding Dishman Carbogen Amcis Ltd
| Funds (Top 4) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
HSBC Flexi Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.5307% | Percentage of the fund’s portfolio invested in the stock 1.04% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 60/81 (-3) |
Motilal Oswal Nifty Microcap 250 Index Fund- Direct- Growth Option Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0357% | Percentage of the fund’s portfolio invested in the stock 0.20% | Change in the portfolio weight of the stock over the last 3 months -0.06% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 181/297 (-14) |
Groww Nifty Total Market Index Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0001% | Percentage of the fund’s portfolio invested in the stock 0.01% | Change in the portfolio weight of the stock over the last 3 months 0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 687/752 (+13) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 12, 2019
Dividend/Share
₹0.20
Ex DateEx Date
Sep 12, 2019
News & Opinions
Dishman Carbogen Q4 earnings effect: Shares plunge 12% in early trade, top losers on BSE
6 months ago•Business Today
Dishman Carbogen declines 10% after Q4 loss widens
6 months ago•Moneycontrol
Dishman Carbogen board OKs 100-cr NCDs issue
8 months ago•Business Standard
Sensex frowned upon bear party, but 36 smallcaps went on joyride last week
8 months ago•Economic Times
Dishman Carbogen gains as board to mull fund raising via NCDs
9 months ago•Business Standard
This beaten down pharma stock has zoomed over 50% in last 11 trading days
9 months ago•Business Standard
Dishman Carbogen spurts after Q3 PAT rises 33% YoY
9 months ago•Business Standard
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 7%, vs industry avg of 8.01%
Decreasing Market Share
Over the last 5 years, market share decreased from 16.39% to 13.87%